OPART/Prodiga, OPART/Protenza, OPART/Paragon
510(k) K993574
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK993574 | Date18 Jan 2000 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LNH
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1000
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The OPART/Prodiga, OPART/Protenza, and OPART/Paragon are Class II magnetic resonance imaging (MRI) systems designed for radiology applications. These devices utilize nuclear magnetic resonance technology to generate detailed images of internal body structures, aiding in the diagnosis and evaluation of various medical conditions.
These MRI systems are intended for use in clinical settings and are supplied as reusable medical equipment. They are classified under product code LNH and comply with FDA 510(k) clearance (K993574) for traditional review. The devices are manufactured by Toshiba America MRI, Inc., and are regulated under the U.S. Food and Drug Administration’s special controls for MRI systems.
Other devices from Toshiba America Mri, Inc.
Questions
AI-generated answers, 19 Sep 2026
Are these MRI systems designed for single-use or can they be reused in a clinical setting?
The OPART/Prodiga, OPART/Protenza, and OPART/Paragon MRI systems are explicitly described as reusable medical equipment for clinical use. Since they are Class II devices intended for repeated imaging procedures, they must follow manufacturer guidelines for maintenance, cleaning, and sterilization to ensure safe and accurate operation.
What regulatory pathway was followed for FDA clearance of these MRI systems?
These devices were cleared through the FDA 510(k) process under traditional review, with a clearance number of K993574. They fall under product code LNH and comply with the agency’s special controls for MRI systems, as indicated in the submission details.
Are there different models or configurations available for these MRI systems?
The data provided lists multiple FEI numbers (e.g., 3008156140, 3021593788) associated with the OPART/Prodiga, OPART/Protenza, and OPART/Paragon systems, suggesting variations in specific configurations or software versions may exist. However, the core technology remains nuclear magnetic resonance imaging for radiology applications, and no distinct clinical indications are specified beyond general diagnostic imaging.
How should these MRI systems be stored to maintain their performance and safety?
While the data does not specify storage conditions in detail, as reusable medical devices, these MRI systems should be stored in a controlled environment—protected from extreme temperatures, humidity, and physical damage—to preserve their structural integrity and calibration. Manufacturer instructions (not provided here) would outline proper storage protocols, including any required maintenance or environmental controls.